RUBYnanomed was founded in 2018 and aims to bring lab discoveries to the clinical market. RUBYnanomed focusses on the non-invasive monitoring of cancer progression, as cancer is a major cause of death worldwide that caused 9.6 million deaths in 2018, and 90 % of those are due to metastasis. We have... Read more
Org chart
Collapse
No reports!
Teams
This company has no teams yet
Offices
This company has no offices yet
